Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 55.00 | 74.50 | 0.7383 | 31.4154 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 74.00 | 74.50 | 0.9933 | 1.1275 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 56.00 | 74.50 | 0.7517 | 26.4741 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 112.00 | 74.50 | 1.5034 | -0.9526 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 78.00 | 74.50 | 1.0470 | 0.3123 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 85.00 | 74.50 | 1.1409 | -0.4038 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 71.00 | 74.50 | 0.9530 | 2.1106 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 61.00 | 74.50 | 0.8188 | 11.5315 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 72.00 | 74.50 | 0.9664 | 1.7359 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 156.25 | 80.34 | 75.00 | 74.50 | 1.0067 | 0.8809 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 90.00 | 74.50 | 1.2081 | -0.6472 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 156.25 | 80.34 | 117.00 | 74.50 | 1.5705 | -0.9683 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 156.25 | 80.34 | 106.00 | 74.50 | 1.4228 | -0.9214 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 156.25 | 80.34 | 588.00 | 74.50 | 7.8926 | -1.0000 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 156.25 | 80.34 | 90.00 | 74.50 | 1.2081 | -0.6472 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 156.25 | 80.34 | 63.00 | 74.50 | 0.8456 | 8.3196 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 156.25 | 80.34 | 108.00 | 74.50 | 1.4497 | -0.9338 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 156.25 | 80.34 | 142.00 | 74.50 | 1.9060 | -0.9946 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 156.25 | 80.34 | 1297.00 | 74.50 | 17.4094 | -1.0000 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 156.25 | 80.34 | 152.00 | 74.50 | 2.0403 | -0.9971 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 140.00 | 74.50 | 1.8792 | -0.9939 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 156.25 | 80.34 | 99.00 | 74.50 | 1.3289 | -0.8529 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 156.25 | 80.34 | 133.00 | 74.50 | 1.7852 | -0.9902 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 156.25 | 80.34 | 83.00 | 74.50 | 1.1141 | -0.2581 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 156.25 | 80.34 | 61.00 | 74.50 | 0.8188 | 11.5315 |